Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference

Rhea-AI Summary

Xtant Medical (NYSE: XTNT) said CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger will participate in the Canaccord Genuity 2026 Musculoskeletal Conference on March 2, 2026, in New Orleans and virtually. A webcast will be available and management will offer virtual one-on-one meetings. A replay will be posted to Xtant's Presentation & Events page for 90 days.

Key Figures

Conference date: March 2, 2026 Webcast availability time: February 2, 2:00 PM ET Replay duration: 90 days

3 metrics

Conference date March 2, 2026 Canaccord Genuity 2026 Musculoskeletal Conference

Webcast availability time February 2, 2:00 PM ET Time webcast presentation becomes available

Replay duration 90 days Replay on Xtant’s Presentations & Events investor webpage

Market Reality Check

Price: $0.5701 Vol: Volume 59,785 vs 20-day a...

low vol

$0.5701 Last Close

Volume Volume 59,785 vs 20-day average 143,572 (relative volume 0.42), indicating muted trading ahead of the conference update. low

Technical Shares at $0.5701 are trading below the 200-day MA of $0.66 and about 39.99% under the 52-week high of $0.95, but above the 52-week low of $0.3401.

Peers on Argus

XTNT was down 2.98% while peers showed mixed moves: APYX down 0.56%, but TELA, B...

XTNT was down 2.98% while peers showed mixed moves: APYX down 0.56%, but TELA, BDMD, LUNG, and NSPR up between 0.77% and 3.35%, suggesting stock-specific factors rather than a uniform sector move.

Historical Context

5 past events · Latest: Dec 11 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 11	Product launch	Positive	-1.1%	Launch of next‑generation nanOss Strata synthetic bone graft product.
Dec 01	Asset sale follow-up	Neutral	+0.0%	Companion Spine completes acquisition of Paradigm Spine assets from Xtant.
Dec 01	Asset divestiture	Positive	+0.0%	Sale of Coflex assets and Paradigm OUS entities to Companion Spine for cash and note.
Nov 10	Earnings report	Positive	+1.1%	Q3 2025 results with revenue growth, higher gross margin, and positive cash flow.
Nov 05	Product launch	Positive	+7.5%	Commercial launch of CollagenX bovine collagen particulate for surgical wound closure.

Pattern Detected

Recent news, especially product launches and earnings, most often saw price moves aligning with the generally positive tone, with one notable divergence on a product launch.

Recent Company History

Over the last few months, Xtant has focused on portfolio reshaping and growth. It launched CollagenX™ on Nov 5, 2025 and nanOss Strata™ on Dec 11, 2025, expanding its biologics and synthetic graft offerings. The company also completed divestitures of Coflex® assets and Paradigm OUS businesses on Dec 1, 2025, and used proceeds to reduce debt. Q3 2025 results on Nov 10, 2025 showed revenue of $33.3M with improved margins. Today’s conference participation fits into an ongoing cycle of commercial and strategic updates.

Market Pulse Summary

This announcement details Xtant’s participation in a musculoskeletal conference on March 2, 2026, in...

Analysis

This announcement details Xtant’s participation in a musculoskeletal conference on March 2, 2026, including a webcast and one-on-one investor meetings. It follows recent product launches and portfolio divestitures, as well as Q3 2025 results with revenue of $33.3M and improved margins. Investors may watch for any new commentary on growth initiatives, integration of recent launches, and use of proceeds from asset sales, along with how management frames its strategic priorities during the presentation.

AI-generated analysis. Not financial advice.

BELGRADE, Mont., Feb. 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 2026 Musculoskeletal Conference, which is being held March 2, 2026, in New Orleans and virtually.

A webcast of the company's presentation will be available here as of Monday, February 2^nd at 2:00 P.M. (ET). In addition, Xtant's management team will be available for virtual one-on-one meetings on that day. Interested investors should contact their representative at Canaccord Genuity. A replay of the presentation will be posted to the Presentation & Events page of Xtant's Investors website for 90 days.

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-participate-in-the-canaccord-genuity-2026-musculoskeletal-conference-302696640.html

SOURCE Xtant Medical Holdings, Inc.

FAQ

When will Xtant Medical (XTNT) present at the Canaccord Genuity 2026 Musculoskeletal Conference?

Xtant will present on March 2, 2026, at the Canaccord Genuity Musculoskeletal Conference. According to the company, senior management will participate in-person in New Orleans and virtually on that date, and investors can request one-on-one virtual meetings through Canaccord Genuity.

Who from Xtant Medical (XTNT) will speak at the March 2, 2026 presentation?

The presenting team includes CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger. According to the company, those executives will deliver the presentation and be available for virtual one-on-one investor meetings that day.

How can investors access Xtant Medical's (XTNT) webcast for the March 2, 2026 event?

A webcast of Xtant's presentation will be available as of Monday, February 2nd at 2:00 P.M. ET. According to the company, the webcast link is provided for the event and a replay will be posted on the Presentation & Events page for 90 days.

Will there be a replay of Xtant Medical's (XTNT) Canaccord Genuity presentation and for how long?

Yes — a replay will be posted to Xtant's Presentation & Events page for 90 days. According to the company, the replay will remain available on the investor website for the stated 90-day period after posting.

Can investors schedule meetings with Xtant Medical (XTNT) management at the March 2, 2026 conference?

Yes — management will be available for virtual one-on-one meetings on March 2, 2026. According to the company, interested investors should contact their Canaccord Genuity representative to arrange those virtual meetings.

Where is the Canaccord Genuity 2026 Musculoskeletal Conference and is Xtant attending virtually?

The conference is held in New Orleans with virtual participation available on March 2, 2026. According to the company, Xtant's executives will attend in person in New Orleans and also offer a virtual presentation option.